or Try an Advanced Search...

    Clinical Trial Stocks List

    Symbol Grade Name % Change
    STTK F Shattuck Labs, Inc. -9.01
    BLRX F BioLineRx Ltd. -40.70
    LXRX F Lexicon Pharmaceuticals, Inc. -4.42
    VTGN F VistaGen Therapeutics, Inc. -3.07
    TCON F TRACON Pharmaceuticals, Inc. -31.40
    VRCA F Verrica Pharmaceuticals Inc. 11.56
    LQDA F Liquidia Technologies, Inc. 0.30
    GLSI F Greenwich LifeSciences, Inc. 0.93
    MREO F Mereo BioPharma Group plc 2.79
    INBX F Inhibrx, Inc. -0.43
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Autoimmune Disease Biotechnology Clinical Research Acute Myeloid Leukemia Advanced Solid Tumors Biopharmaceutical Development Cancer Central Nervous System Disease Clinical Development Clinical Pharmacology Compugen Drug Discovery Hematological Cancers Infarction Infectious Diseases Inflammatory Bowel Disease Life Sciences Lymphoma Myocardial Infarction Nerve

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial stocks.

    Symbol Grade Name Weight
    TXSS A Texas Small Cap Equity Index ETF 0.04
    RFLR B Innovator U.S. Small Cap Power Buffer ETF - September Innovator U.S. Small Cap Managed Floor ETF 0.02
    VTWO B Vanguard Russell 2000 ETF 0.01
    IWC B iShares Microcap ETF 0.01
    VTI A Vanguard Total Stock Market ETF 0.0
    View all Clinical Trial ETFs...
    Compare ETFs
    Compare IWC to VTI Compare RFLR to VTI Compare TXSS to VTWO

        Clinical Trial Stocks Recent News

        Date Stock Title
        Nov 21 BLRX BioLineRx inks licensing deal, share purchase agreement
        Nov 21 BLRX BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
        Nov 20 LXRX Lexicon Appoints Ivan H. Cheung to Board of Directors
        Nov 20 BLRX BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
        Nov 19 LQDA 3 US Growth Stocks With At Least 10% Insider Ownership
        Nov 18 LXRX Lexicon Pharmaceuticals (NASDAQ:LXRX investor three-year losses grow to 80% as the stock sheds US$107m this past week
        Nov 17 INBX The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
        Nov 16 STTK Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 LQDA Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off
        Nov 15 STTK Shattuck Labs sees cash runway into 2027
        Nov 15 INBX Inhibrx Biosciences GAAP EPS of -$2.84
        Nov 15 LQDA Liquidia Third Quarter 2024 Earnings: Beats Expectations
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biotechnology Clinical Research Drug Discovery Medicine Biomarkers Biopharmaceutical Cataracts Chemotherapy Clinical Pharmacology Clinical Trial Product Inflammation Non Small Cell Lung Cancer Nursing Research Pain Pharmaceutical Product Testing Small Cell Lung Cancer Active Pharmaceutical Ingredients Acute And Chronic Pain Acute Myeloid Leukemia
        Clinical Trial

        A clinical trial is a research study in which people volunteer to test new treatments, interventions, or tests as a means to prevent, detect, or treat diseases or conditions. Clinical trials are conducted to determine the safety and effectiveness of new drugs, medical devices, or other treatments.

        Browse All Tags